Sinusitis — Gold Laser Vs. Micro-Debriders for Functional Endoscopic Sinus Surgery
Citation(s)
Alobid I, Bernal-Sprekelsen M, Mullol J Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient's quality of life. Allergy. 2008 Oct;63(10):1267-79. doi: 10.1111/j.1398-9995.2008.01828.x. Review.
Benninger MS, Senior BA The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg. 1997 Nov;123(11):1175-9.
Bhattacharyya N Chronic rhinosinusitis: is the nose really involved? Am J Rhinol. 2001 May-Jun;15(3):169-73.
Blackwell DL, Lucas JW, Clarke TC Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat 10. 2014 Feb;(260):1-161.
Chester AC, Sindwani R Symptom outcomes in endoscopic sinus surgery: a systematic review of measurement methods. Laryngoscope. 2007 Dec;117(12):2239-43. doi: 10.1097/MLG.0b013e318149224d. Review.
Gliklich RE, Hilinski JM Longitudinal sensitivity of generic and specific health measures in chronic sinusitis. Qual Life Res. 1995 Feb;4(1):27-32.
Gliklich RE, Metson R Techniques for outcomes research in chronic sinusitis. Laryngoscope. 1995 Apr;105(4 Pt 1):387-90.
Lee JC, Lai WS, Ju DT, Chu YH, Yang JM Diode laser assisted minimal invasive sphenoidotomy for endoscopic transphenoidal pituitary surgery: our technique and results. Lasers Surg Med. 2015 Mar;47(3):239-42. doi: 10.1002/lsm.22340.
McCaig LF, Hughes JM Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995 Jan 18;273(3):214-9. Erratum in: JAMA 1998 Feb 11;279(6):434.
Metson R Holmium:YAG laser endoscopic sinus surgery: a randomized, controlled study. Laryngoscope. 1996 Jan;106(1 Pt 2 Suppl 77):1-18.
Metson RB, Gliklich RE Clinical outcomes in patients with chronic sinusitis. Laryngoscope. 2000 Mar;110(3 Pt 3):24-8.
Poetker DM, Litvack JR, Mace JC, Smith TL Recurrent acute rhinosinusitis: presentation and outcomes of sinus surgery. Am J Rhinol. 2008 May-Jun;22(3):329-33. doi: 10.2500/ajr.2008.22.3177.
Rudmik L, Hopkins C, Peters A, Smith TL, Schlosser RJ, Soler ZM Patient-reported outcome measures for adult chronic rhinosinusitis: A systematic review and quality assessment. J Allergy Clin Immunol. 2015 Dec;136(6):1532-1540.e2. doi: 10.1016/j.jaci.2015.10.012. Review.
Senior BA, Glaze C, Benninger MS Use of the Rhinosinusitis Disability Index (RSDI) in rhinologic disease. Am J Rhinol. 2001 Jan-Feb;15(1):15-20.
Soler ZM, Hyer JM, Karnezis TT, Schlosser RJ The Olfactory Cleft Endoscopy Scale correlates with olfactory metrics in patients with chronic rhinosinusitis. Int Forum Allergy Rhinol. 2016 Mar;6(3):293-8. doi: 10.1002/alr.21655. Epub 2015 Dec 31.
Comparing Post-Operative Outcomes Between Gold Laser and Micro-Debriders for Functional Endoscopic Sinus Surgery (FESS) in Patients With Chronic Sinusitis
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
